1. Patent Search
  2. Details

PROCESS FOR PREPARING ALPHA-SILYLAMINE COMPOUNDS FROM ALPHA-SILYLMETHYL AZIDE COMPOUNDS

20170210765 · 2017-07-27

    Inventors

    Cpc classification

    International classification

    Abstract

    The present invention relates to a process for preparing alpha-silylamine compounds and, more specifically, to a one-pot process for preparing various alpha-silylamine compounds by reacting, in the presence of a metal complex catalyst and under a mild condition, an alpha-silylmethyl azide compound as a starting material with various allylborate compounds via an alpha-silylimine intermediate which has no substituent at nitrogen.

    Claims

    1. A method of preparing an -silylamine compound of the following Chemical Formula 1 comprising: photoreacting an -silylmethyl azide compound of the following Chemical Formula 2 with a boronate compound of the following Chemical Formula 3 in the presence of a metal complex catalyst: ##STR00087## wherein R.sub.1, R.sub.2 and R.sub.3 are independently of each other (C1-C20)alkyl; when R and R are linked by ##STR00088## to form a ring, Y is ##STR00089## and Z is ##STR00090## or Y is ##STR00091## and Z is ##STR00092## when R and R are ##STR00093## Y is ##STR00094## and Z is ##STR00095## and R.sub.4, R.sub.5 and R.sub.6 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    2. The method of claim 1, wherein the -silylmethyl azide compound of the following Chemical Formula 2 is photoreacted with an allylboronate compound of the following Chemical Formula 3-a in the presence of a metal complex catalyst, to prepare an -silylamine compound of the following Chemical Formula 1-a: ##STR00096## wherein R.sub.1, R.sub.2 and R.sub.3 are independently of each other (C1-C20)alkyl; R and R are ##STR00097## or R and R are linked by ##STR00098## to form a ring; and R.sub.4, R.sub.5 and R.sub.6 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    3. The method of claim 1, wherein the -silylmethyl azide compound of the following Chemical Formula 2 is photoreacted with an allenylboronate compound of the following Chemical Formula 3-b in the presence of a metal complex catalyst, to prepare an -silylamine compound of the following Chemical Formula 1-b: ##STR00099## wherein R.sub.1, R.sub.2 and R.sub.3 are independently of each other (C1-C20)alkyl.

    4. The method of claim 1, wherein the metal complex catalyst is a ruthenium complex catalyst.

    5. The method of claim 4, wherein the ruthenium complex catalyst is represented by the following structure: ##STR00100## wherein R.sub.11 and R.sub.12 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl; R.sub.13 is NR.sub.14R.sub.15, OR.sub.16, C(O)NR.sub.17R.sub.18 or C(O)OR.sub.19; and R.sub.14 to R.sub.19 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    6. The method of claim 5, wherein the ruthenium complex catalyst is represented by the following structure: ##STR00101##

    7. The method of claim 1, wherein the photoreaction is carried out under irradiation of visible light.

    8. The method of claim 1, wherein the boronate compound of Chemical Formula 3 is selected from the group consisting of boronate compounds represented by the following Chemical Formulae 4 to 6: ##STR00102## wherein R.sub.4, R.sub.5 and R.sub.6 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    9. The method of claim 8, wherein when the boronate compound of Chemical Formula 4 or 5 is used, reaction temperature is room temperature to 50 C.

    10. The method of claim 8, wherein when the boronate compound of Chemical Formula 6 is used, tri(C1-C10)alkyl borane is further added.

    11. The method of claim 10, wherein a mixture of the silylmethyl azide compound of Chemical Formula 2 and tri(C1-C10)alkyl borane is irradiated with visible light at room temperature to 50 C. in the presence of the ruthenium catalyst, and then the boronate compound of Chemical Formula 6 is added thereto at 78 C. to room temperature.

    Description

    BEST MODE

    [0042] As a result of conducting a study in order to develop a method of efficiently preparing an -silylamine compound, the present inventors have developed a method of preparing an -silylamine compound having substituents and multiple stereocenters including high diastereoselectivity and enantioselectivity, and a geometry of double bond, which was not able to be produced in the past, by photoreacting an -silylmethyl azide compound with an allylboronate or allenylboronate compound in the presence of a metal complex catalyst.

    [0043] The present invention provides a method of preparing an -silylamine compound of the following Chemical Formula 1 by photoreacting an -silylmethyl azide compound of the following Chemical Formula 2 with a boronate compound of the following Chemical Formula 3 in the presence of a metal complex catalyst:

    ##STR00019##

    [0044] wherein R.sub.1, R.sub.2 and R.sub.3 are independently of each other (C1-C20)alkyl;

    [0045] when R and R are linked by

    ##STR00020##

    to form a ring, Y is

    ##STR00021##

    and Z is

    [0046] ##STR00022##

    or Y is

    [0047] ##STR00023##

    and Z is

    [0048] ##STR00024##

    [0049] when R and R are

    ##STR00025##

    Y is

    [0050] ##STR00026##

    and Z is

    [0051] ##STR00027##

    and

    [0052] R.sub.4, R.sub.5 and R.sub.6 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    [0053] The preparation method of the present invention includes photoreact ing an -silylmethyl azide compound of the following Chemical Formula 2 with an allylboronate compound of the following Chemical Formula 3-a in the presence of a metal complex catalyst, to prepare an -silylamine compound of the following Chemical Formula 1-a:

    ##STR00028##

    [0054] wherein R.sub.1, R.sub.2 and R.sub.3 are independently of each other (C1-C20)alkyl;

    [0055] R and R are

    ##STR00029##

    or R and R are linked by

    ##STR00030##

    to form a ring; and

    [0056] R.sub.4, R.sub.5 and R.sub.6 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    [0057] In addition, the preparation method of the present invention includes photoreacting an -silylmethyl azide compound of the following Chemical Formula 2 with an allenylboronate compound of the following Chemical Formula 3-b in the presence of a metal complex catalyst, to prepare an -silylamine compound of the following Chemical Formula 1-b:

    ##STR00031##

    [0058] wherein R.sub.1, R.sub.2 and R.sub.3 are independently of each other (C1-C20)alkyl.

    [0059] The metal complex catalyst may be a ruthenium complex catalyst, but not limited thereto.

    [0060] Preferably, the ruthenium complex catalyst is represented by the following structure:

    ##STR00032##

    [0061] wherein R.sub.11 and R.sub.12 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl;

    [0062] R.sub.13 is NR.sub.14R.sub.15, OR.sub.16, C(O)NR.sub.17R.sub.18 or C(O)OR.sub.19;

    [0063] R.sub.14 to R.sub.19 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    [0064] More preferably, the ruthenium complex catalyst is represented by the following structure:

    ##STR00033##

    [0065] The reaction of the present invention is briefly shown in the following Reaction Formula 1:

    ##STR00034##

    [0066] The photoreaction is carried out under irradiation of visible light, from which an imine intermediate having no substituent on nitrogen may be formed, and the formed -silylimine intermediate having no substituent on nitrogen may be reacted with an allyl or allenyl nucleophile to prepare various -silylamine compounds. Here, the irradiation of visible light may be carried out by using a 30 W household fluorescent light, as described in the Example of the present invention, and there is no limitation as long as visible light may be irradiated therefrom. The -silylimine intermediate having no substituent on nitrogen may be formed at room temperature to 50 C. for an appropriate time under inert gas such as nitrogen.

    [0067] The preparation of the -silylamine compound by an addition reaction of the -silylimine intermediate produced from an -silylmethyl azide compound of Chemical Formula 2 with the boronate compound of Chemical Formula 3 may be carried out at 78 C. to room temperature under inert gas such as nitrogen gas.

    [0068] The boronate compound of Chemical Formula 3 is an allyl or allenylboronate compound, and more preferably represented by the following Chemical Formulae 4 to 6:

    ##STR00035##

    [0069] wherein R.sub.4, R.sub.5 and R.sub.6 are independently of each other hydrogen, (C1-C20)alkyl or (C6-C20)aryl.

    [0070] When the allyl or allenylboronate compound of Chemical Formula 4 or 5 is used, the formation of the -silylimine intermediate having no substituent on nitrogen is carried out at room temperature to 50 C. for an appropriate time, and the preparation of the -silylamine compound by the addition reaction of the produced -silylimine intermediate with the allyl or allenylboronate compound of Chemical Formula 4 or 5 is carried out at room temperature for an appropriate time.

    [0071] In addition, when the allylboronate compound of Chemical Formula 6 is used, tri(C1-C10)alkyl borane may be further added, and more preferably a mixture of the silylmethyl azide compound of Chemical Formula 2 and tri(C1-C10)alkyl borane may be irradiated with visible light at room temperature to 50 C. in the presence of the ruthenium catalyst, to form an -silylimine intermediate having no substituent on nitrogen, and the boronate compound of Chemical Formula 6 may be added thereto at 78 C. to room temperature, more preferably 78 C., to prepare the -silylamine compound.

    [0072] An equivalent ratio of the -silylmethyl azide compound of Chemical Formula 2 and the borate compound of Chemical Formula 3, used in the reaction may be varied, but preferably 1:1.1 to 2.0, and more preferably 1:1.5. An organic solvent used in the reaction may be tetrahydrofuran, toluene, benzene, ethyl acetate, etc., and preferably tetrahydrofuran is used. An amount of the metal complex catalyst used in the reaction is 1 to 3 mol %, but varied with the kinds of -silylmethyl azide compound of Chemical Formula 2 to be used, and preferably 1.5 to 2 mol %.

    [0073] The reaction for preparing the -silylamine compound of the present invention is an addition reaction of an -silylimine compound having no substituent on nitrogen formed from the -silylmethyl azide with a borate compound, and includes a diastereoselective addition reaction and an asymmetric addition reaction depending on the structure of the borate compound.

    [0074] Hereinafter, the constitution of the present invention is described in detail by the following Examples, but which are only for illuminating the present invention, and the scope of the present invention is not limited thereto.

    Examples 1 to 7: Addition Reaction Between Imine Having No Substituent on Nitrogen Produced from Silyl Azide Having -Hydrogen and Allylborate Compound

    [0075] In the present Examples, a ruthenium complex A of the following structure was used as a catalyst, to synthesize an -silylimine intermediate having no substituent on nitrogen from silyl azide having -hydrogen, and at the same time to carry out a continuous addition reaction of an allylborate compound, thereby preparing an -silylamine compound.

    ##STR00036##

    [Example 1] Preparation of -Silylamine Compound 1

    [0076] A ruthenium catalyst A (5.1 mg, 0.005 mmol) was added to THF (0.25 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of trimethylsilylmethyl azide (32.3 mg, 0.25 mmol) and allylboronic acid pinacol ester (68.2 L, 0.375 mmol) dissolved in THF (0.25 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. When stirring was completed, chloroform (1 mL) was added thereto to finish the reaction, and stirring was carried out for another 5 minutes. Then, the reactant was transferred to a separatory funnel, and acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (55 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration.

    [0077] The concentrated solution was directly dissolved in dichloromethane (CH.sub.2Cl.sub.2, 5 mL, 0.05 M) without a further purification process, and triethylamine (70 L, 0.50 mmol) and p-toluenesulfonyl chloride (71.5 mg, 0.375 mmol) were added thereto. The reaction mixture was stirred for 12 hours at room temperature. When stirring was completed, water (3 mL) was added thereto to finish the reaction, and then dichloromethane (33 mL) was added to perform extraction. Water was removed by Na.sub.2SO.sub.4 from collected organic layer, which was concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm13 cm, eluenthexane:ethyl acetate=80:20) gave a solid -silylamine compound 1 (61.7 mg, 0.208 mmol, 83% yield). R.sub.f=0.56 (hexane:EtOAc=80:20). m.p. 109 C.

    [0078] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.00 (s, 9H), 2.01-2.24 (m, 2H), 2.42 (s, 3H), 2.89 (dt, J=9.6, 2.6 Hz, 1H), 4.31 (d, J=9.6 Hz, 1H), 4.77-4.88 (m, 1H), 4.93 (dt, J=10.2, 0.9 Hz, 1H), 5.53 (dddd, J=17.1, 10.1, 7.8, 6.9 Hz, 1H), 7.29 (d, J=8.1 Hz, 2H), 7.76 (d, J=8.1 Hz, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =2.7, 21.7, 36.1, 43.7, 118.3, 127.5, 129.7, 135.1, 138.6, 143.4; IR: (cm.sup.1) v 3273, 3071, 2958, 2893, 1640, 1597, 1496, 1321, 1252, 1162, 1094; HRMS (FAB+) calcd for C.sub.14H.sub.24NO.sub.2SiS: 298.1297, found: 298.1299.

    [Example 2] Preparation of -Silylamine Compound 2

    [0079] A ruthenium catalyst A (35.6 mg, 0.035 mmol) was added to THF (1.75 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of dimethylphenylsilylmethyl azide (334.8 mg, 1.75 mmol and allylboronic acid pinacol ester (0.48 mL, 0.375 mmol) dissolved in THF (1.75 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. When stirring was completed, chloroform (3 mL) was added thereto to finish the reaction, and stirring was carried out for another 5 minutes. Then, the reactant was transferred to a separatory funnel, and acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (55 mL), and water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. Purification with preparative TLC (PTLC, 10 cm15 cm, eluenthexane: isopropylamine=95:5) gave an -silylamine compound 2 (291.6 mg, 1.42 mmol, 81% yield). R.sub.f=0.34 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0080] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.34 (s, 6H), 1.17 (br s, 2H), 1.85-2.03 (m, 1H), 2.30-2.48 (m, 2H), 4.95-5.12 (m, 2H), 5.56-5.81 (m, 1H), 7.30-7.44 (m, 3H), 7.52-7.63 (m, 2H); .sup.13C-NMR (75 MHz, CDCl.sub.3): =5.3, 5.0, 38.7, 40.2, 117.1, 128.1, 129.4, 134.3, 137.2, 137.2; IR: (cm.sup.1) v 3370, 3070, 2957, 2900, 1637, 1428, 1248, 1114, 998; HRMS (ESI+) calcd for C.sub.12H.sub.20NSi: 206.1360, found: 206.1359.

    [Example 3] Preparation of -Silylamine Compound 3

    [0081] A ruthenium catalyst A (5.1 mg, 0.005 mmol) was added to THF (0.25 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of methyldiphenylsilylmethyl azide (63.3 mg, 0.25 mmol and allylboronic acid pinacol ester (68.2 L, 0.75 mmol) dissolved in THF (0.25 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. When stirring was completed, chloroform (1 mL) was added thereto to finish the reaction, and stirring was carried out for another 5 minutes. Then, the reactant was concentrated under a reduced pressure condition, dissolved in hexane (2 mL), transferred to a separatory funnel, and acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (55 mL), and water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. Purification with preparative TLC (PTLC, 10 cm15 cm, eluenthexane: isopropylamine=95:5) gave an -silylamine compound 3 (46.1 mg, 0.172 mmol, 69% yield). R.sub.f=0.68 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0082] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.64 (s, 3H), 1.65 (br s, 2H), 2.04 (ddd, J=13.8, 11.3, 8.7 Hz, 1H), 2.44 (ddd, J=14.0, 5.4, 1.7 Hz, 1H), 2.85 (dd, J=11.3, 2.9 Hz, 1H), 5.02-5.12 (m, 2H), 5.74 (dddd, J=19.1, 14.0, 5.9, 5.7 Hz, 1H), 7.32-7.47 (m, 6H), 7.58-7.66 (m, 4H); .sup.13C NMR (75 MHz, CDCl.sub.3): =6.3, 38.5, 39.2, 117.4, 128.2, 128.2, 129.7, 129.7, 135.1, 135.2, 135.3, 137.0; IR: (cm.sup.1) v 3355, 3069, 3049, 2998, 2974, 2921, 1823, 1637, 1487, 1305, 1252, 1191, 1113, 1029, 998; HRMS (FAB+) calcd for C.sub.17H.sub.22NSi: 268.1522, found: 268.1521.

    [Example 4] Preparation of -Silylamine Compound 4

    [0083] A solid -silylamine compound (49.1 mg, 0.166 mmol, 67% yield) was obtained in the same manner as in Example 1, except that trimethylsilylmethyl azide (32.3 mg, 0.25 mmol), a ruthenium catalyst A (5.1 mg, 0.005 mmol), and allenylboronic acid pinacol ester (134 L, 0.750 mmol) were stirred at 50 C. for 5 hours under irradiation of a 30 W fluorescent light. m.p. 104 C.

    [0084] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.04 (s, 9H), 1.94 (t, J=2.7 Hz, 1H), 2.17 (dt, J=17.1, 3.0 Hz, 1H), 2.32 (ddd, J=17.1, 6.6, 2.7 Hz, 1H), 2.42 (s, 3H), 2.87 (ddd, J=9.9, 6.6, 3.0 Hz, 1H), 4.77 (d, J=10.2 Hz, 1H), 7.28 (d, J=8.1 Hz, 2H), 7.78 (d, J=8.4 Hz, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =2.8, 21.1, 21.7, 41.9, 71.5, 81.4, 127.4, 129.8, 138.4, 143.6; IR: (cm.sup.1) v 3306, 3063, 2957, 2925, 2854, 1724, 1651, 1599, 1494, 1327, 1289, 1252, 1184, 1094; HRMS (FAB+) calcd for C.sub.14H.sub.22NO.sub.2SiS: 296.1141, found: 296.1139.

    [Example 5] Preparation of -Silylamine Compound 5

    [0085] An -silylamine compound 5 (40.9 mg, 0.201 mmol, 80% yield) was obtained in the same manner as in Example 2, except that dimethylphenylsilylmethyl azide (47.8 mg, 0.25 mmol), a ruthenium catalyst A (5.1 mg, 0.005 mmol), and allenylboronic acid pinacol ester (134 L, 0.750 mmol) were stirred at 50 C. for 3 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.61 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0086] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.37 (s, 6H), 1.41 (br s, 2H), 2.00 (t, J=2.6 Hz, 1H), 2.16 (ddd, J=16.8, 9.9, 2.6 Hz, 1H), 2.40 (ddd, J=16.8, 3.9, 2.7 Hz, 1H), 2.53 (dd, J=9.9, 3.9 Hz, 1H), 7.36-7.44 (m, 3H), 7.53-7.62 (m, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): ==5.1, 5.1, 24.7, 40.4, 70.2, 83.3, 128.1, 129.6, 134.2, 136.5; IR: (cm.sup.1) v 3304, 3069, 2049, 2957, 2899, 1489, 1488, 1427, 1250, 1113, 998; HRMS (ESI+) calcd for C.sub.12H.sub.18NSi: 204.1203, found: 204.1203.

    [Example 6] Preparation of -Silylamine Compound 6

    [0087] An -silylamine compound 6 (56.5 mg, 0.213 mmol, 85% yield) was obtained in the same manner as in Example 3, except that methyldiphenylsilylmethyl azide (63.3 mg, 0.25 mmol), a ruthenium catalyst A (5.1 mg, 0.005 mmol), and allenylboronic acid pinacol ester (134 L, 0.750 mmol) were stirred at 50 C. for 3 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.76 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0088] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.65 (s, 3H), 1.57 (br s, 2H), 2.02 (t, J=2.7 Hz, 1H), 2.25 (ddd, J=16.8, 7.5, 2.5 Hz, 1H), 2.49 (ddd, J=16.8, 3.3, 2.8 Hz, 1H), 2.97 (dd, J=10.5, 3.6 Hz, 1H), 7.33-7.49 (m, 6H), 7.61-7.71 (m, 4H); .sup.13C NMR (75 MHz, CDCl.sub.3): =6.3, 24.7, 39.4, 70.3, 83.2, 128.2, 129.9, 129.9, 134.6, 134.8, 135.1, 135.2; IR: (cm.sup.1) v 3364, 3293, 3069, 3048, 2957, 2922, 1489, 1487, 1428, 1253, 1191, 1113, 998; HRMS (ESI+) calcd for C.sub.17H.sub.20NSi: 266.1360, found: 266.1360.

    [Example 7] Preparation of -Silylamine Compound 7

    [0089] A solid -silylamine compound 7 (56.4 mg, 0.173 mmol, 69% yield) was obtained in the same manner as in Example 1, except that trimethylsilylmethyl azide (32.3 mg, 0.25 mmol), a ruthenium catalyst A (5.1 mg, 0.005 mmol), and 3,3-dimethylallylboronic acid pinacol ester (83 L, 0.375 mmol) were stirred at 50 C. for 5 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.49 (hexane:EtOAc=90:10). m.p. 153 C.

    [0090] .sup.1H NMR (500 MHz, CDCl.sub.3): =0.02 (s, 9H), 0.88 (s, 3H), 0.94 (s, 3H), 2.40 (s, 3H), 2.95 (d, J=10.0 Hz, 1H), 4.25 (d, J=10.0 Hz, 1H), 4.93-5.21 (m, 2H), 5.68 (dd, J=17.5, 10.5 Hz, 1H), 7.26 (d, J=8.0 Hz, 2H), 7.72 (d, J=8.0 Hz, 2H); .sup.13C NMR (125 MHz, CDCl.sub.3): =0.1, 21.7, 25.5, 27.2, 41.8, 55.0, 112.9, 127.1, 129.6, 139.8, 143.0, 146.0; IR: (cm.sup.1) v 3302, 3081, 3062, 2967, 2933, 1639, 1598, 1497, 1380, 1252, 1155, 1094; HRMS (ESI+) calcd for C.sub.16H.sub.27NO.sub.2SSiNa: 348.1424, found: 348.1425.

    [0091] It was confirmed from the above Examples 1 to 7 that the -silylamine compound was produced with a high yield by an addition reaction between imine having no substituent on nitrogen produced from silyl azide having -hydrogen and an allylborate compound.

    Examples 8 to 14 Diastereoselective Addition Reaction Between Imine Having No Substituent on Nitrogen Produced from Silyl Azide Having -Hydrogen and Allylborate Compound

    [0092] In the present Examples, a ruthenium complex A was used as a catalyst, to synthesize an -silylimine intermediate having no substituent on nitrogen from silyl azide having -hydrogen, and at the same time to carry out a diastereoselective addition reaction of an allylborate compound, thereby preparing an -silylamine compound.

    [Example 8] Preparation of -Silylamine Compound 8

    [0093] A solid -silylamine compound 8 (77.6 mg, 0.249 mmol, 83% yield) was obtained in the same manner as in Example 1, except that trimethylsilylmethyl azide (38.8 mg, 0.30 mmol), a ruthenium catalyst A (6.1 mg, 0.006 mmol), and cis-crotylboronic acid pinacol ester (81.9 mg, 0.45 mmol) were stirred at room temperature for 5 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.24 (hexane:EtOAc=90:10). m.p. 129 C.

    [0094] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.01 (s, 9H), 0.90 (d, J=7.2 Hz, 3H), 2.18-2.30 (m, 1H), 2.41 (s, 3H), 2.86 (dd, J=9.9, 4.2 Hz, 1H), 4.35-4.51 (m, 1H), 4.73-4.92 (m, 2H), 5.55 (ddd, J=17.1, 10.2, 8.7 Hz, 1H), 7.28 (d, J=8.1 Hz, 2H), 7.75 (d, J=8.4 Hz, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =1.2, 17.9, 21.7, 41.8, 49.6, 115.4, 127.3, 129.7, 138.9, 141.7, 143.3; IR: (cm.sup.1) v 3281, 2961, 2851, 1597, 1496, 1319, 1253, 1158, 1094; HRMS (FAB+) calcd for C.sub.15H.sub.26NO.sub.2SiS: 312.1454, found: 312.1451.

    [Example 9] Preparation of -Silylamine Compound 9

    [0095] A solid -silylamine compound 9 (76.9 mg, 0.247 mmol, 82% yield) was obtained in the same manner as in Example 1, except that trimethylsilylmethyl azide (38.8 mg, 0.30 mmol), a ruthenium catalyst A (6.1 mg, 0.006 mmol), and trans-crotylboronic acid pinacol ester (86.2 mg, 0.45 mmol) were stirred at room temperature for 5 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.24 (hexane:EtOAc=90:10). m.p. 142 C.

    [0096] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.03 (s, 9H), 0.89 (d, J=6.9 Hz, 1H), 2.38-2.50 (m, 4H), 2.87 (dd, J=9.6, 3.6 Hz, 1H), 4.21-4.39 (m, 1H), 4.90-5.08 (m, 2H), 5.62 (ddd, J=17.1, 10.5, 6.9 Hz, 1H), 7.24-7.31 (m, 2H), 7.74 (d, J=8.4 Hz, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =1.7, 17.9, 21.7, 40.1, 49.7, 115.5, 127.3, 129.7, 138.9, 140.8, 143.2; IR: (cm.sup.1) v 3277, 2961, 1598, 1496, 1321, 1290, 1253, 1094; HRMS (FAB+) calcd for C.sub.15H.sub.26NO.sub.2SiS: 312.1454, found: 312.1451.

    [Example 10] Preparation of -Silylamine Compound 10

    [0097] An -silylamine compound 10 (47.1 mg, 0.207 mmol, 77% yield) was obtained in the same manner as in Example 3, except that trimethylsilylmethyl azide (34.9 mg, 0.27 mmol), a ruthenium catalyst A (5.4 mg, 0.0054 mmol), and trans-non-2-enyl boronic acid pinacol ester (102.1 mg, 0.405 mmol) were stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.49 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0098] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.05 (s, 9H), 0.87 (t, J=6.6 Hz, 3H), 1.18-1.49 (m, 12H), 2.03-2.21 (m, 2H), 4.92-5.12 (m, 2H), 5.63 (dq, J=10.4, 8.7 Hz, 1H); .sup.13C NMR (75 MHz, CDCl.sub.3): =2.1, 14.3, 22.9, 27.6, 29.5, 32.1, 32.3, 45.0, 48.0, 116.2, 140.9; IR: (cm.sup.1) v 3370, 2956, 2926, 2856, 1467, 1247, 912; HRMS (ESI+) calcd for C.sub.13H.sub.30NSi: 228.2142, found: 228.2142.

    [Example 11] Preparation of -Silylamine Compound 11

    [0099] An -silylamine compound 11 (41.4 mg, 0.189 mmol, 76% yield) was obtained in the same manner as in Example 2, except that trimethylsilylmethyl azide (32.3 mg, 0.25 mmol), a ruthenium catalyst A (5.1 mg, 0.005 mmol), and cinnamyl boronic acid pinacol ester (91.6 mg, 0.375 mmol) were stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.49 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0100] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.15 (s, 9H), 1.23 (br s, 2H), 2.49 (d, J=8.7 Hz, 1H), 3.27 (t, J=9.0 Hz, 1H), 5.10-5.25 (m, 2H), 6.01 (dt, J=17.4, 9.6 Hz, 1H), 7.15-7.34 (m, 5H); .sup.13C NMR (75 MHz, CDCl.sub.3): =2.7, 45.7, 55.5, 116.5, 126.7, 128.2, 128.8, 140.5, 143.4; IR: (cm.sup.1) v 3371, 3027, 2953, 1688, 1493, 1452, 1247, 992; HRMS (FAB+) calcd for C.sub.13H.sub.22NSi: 220.1522, found: 220.1524.

    [Example 12] Preparation of -Silylamine Compound 12

    [0101] An -silylamine compound 12 (201.3 mg, 0.190 mmol, 71% yield) was obtained in the same manner as in Example 2, except that trimethylsilylmethyl azide (172.3 mg, 1.33 mmol), a ruthenium catalyst A (27.0 mg, 0.025 mmol), and trans-oct-2-en-4-yl boronic acid pinacol ester (476.4 mg, 2.0 mmol) were stirred at room temperature for 6 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.46 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0102] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.06 (s, 9H), 0.85-0.93 (m, 3H), 0.97 (d, J=6.9 Hz, 3H), 1.23-1.40 (m, 6H), 1.93-2.15 (m, 3H), 2.56 (dquint, J=9.6, 6.9 Hz, 1H), 5.21 (tt, J=10.4, 1.5 Hz, 1H), 5.40 (dt, J=10.8, 7.2 Hz, 1H); .sup.13C NMR (75 MHz, CDCl.sub.3): =2.1, 14.2, 19.8, 22.6, 27.6, 32.3, 36.1, 47.0, 130.3, 134.0; IR: (cm.sup.1) v 3447, 2957, 2928, 2859, 1459, 1372, 1247, 836; HRMS (ESI+) calcd for C.sub.12H.sub.25NSi: 214.1986, found: 214.1986.

    [Example 13] Preparation of -Silylamine Compound 13

    [0103] An -silylamine compound 13 (164.2 mg, 0.748 mmol, 75% yield) was obtained in the same manner as in Example 2, except that dimethylphenylsilylmethyl azide (191.3 mg, 1.0 mmol), a ruthenium catalyst A (20.4 mg, 0.02 mmol), and cis-crotylboronic acid pinacol ester (273 mg, 1.5 mmol) were stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.30 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0104] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.37 (s, 3H), 0.37 (s, 3H), 0.94 (d, J=6.9 Hz, 3H), 1.07 (br s, 2H), 2.30-2.41 (m, 1H), 2.43 (d, J=4.2 Hz, 1H), 4.90-5.09 (m, 2H), 5.77 (ddd, J=17.1, 10.5, 6.3 Hz, 1H), 7.34-7.43 (m, 3H), 7.55-7.68 (m, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =3.9, 3.3, 15.0, 40.7, 45.8, 114.0, 128.0, 129.3, 134.3, 138.2, 143.3; IR: (cm.sup.1) v 3371, 3069, 3050, 2960, 2872, 1821, 1635, 1454, 1374, 1248, 1191, 1060, 988; HRMS (FAB+) calcd for C.sub.13H.sub.22NSi: 220.1522, found: 220.1524.

    [Example 14] Preparation of -Silylamine Compound 14

    [0105] An -silylamine compound 14 (49.3 mg, 0.225 mmol, 80% yield) was obtained in the same manner as in Example 2, except that dimethylphenylsilylmethyl azide (53.5 mg, 0.28 mmol), a ruthenium catalyst A (5.7 mg, 0.006 mmol), and trans-crotylboronic acid pinacol ester (76.5 mg, 0.42 mmol) were stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.30 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0106] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.37 (s, 6H), 1.00 (d, J=6.6 Hz, 3H), 1.24 (br s, 2H), 2.23-2.40 (m, 2H), 4.92-5.09 (m, 2H), 5.61-5.77 (m, 1H), 7.31-7.42 (m, 3H), 7.52-7.61 (m, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =4.0, 3.5, 18.7, 42.1, 46.1, 115.0, 128.0, 129.2, 134.2, 138.4, 142.3; IR: (cm.sup.1) v 3371, 3069, 2959, 2927, 1637, 1487, 1458, 1248, 1112, 998; HRMS (FAB+) calcd for C.sub.13H.sub.22NSi: 220.1522, found: 220.1523.

    [0107] It was confirmed from the above Examples 8 to 14 that the -silylamine compound was produced in a high yield by a diastereoselective addition reaction between imine having no substituent on nitrogen produced from silyl azide having -hydrogen and an allylborate compound.

    [0108] The structures of -silylazide compound and allylborate compound used in Examples 1 to 14, and -silylamine compound produced therefrom are shown in the following Table 1:

    TABLE-US-00001 TABLE 1 Reactant Product -silylazide -silylamine Example compound Allylborate compound compound 1 [00037]embedded image [00038]embedded image [00039]embedded image 2 [00040]embedded image [00041]embedded image [00042]embedded image 3 [00043]embedded image [00044]embedded image [00045]embedded image 4 [00046]embedded image [00047]embedded image [00048]embedded image 5 [00049]embedded image [00050]embedded image [00051]embedded image 6 [00052]embedded image [00053]embedded image [00054]embedded image 7 [00055]embedded image [00056]embedded image [00057]embedded image 8 [00058]embedded image [00059]embedded image [00060]embedded image 9 [00061]embedded image [00062]embedded image [00063]embedded image 10 [00064]embedded image [00065]embedded image [00066]embedded image 11 [00067]embedded image [00068]embedded image [00069]embedded image 12 [00070]embedded image [00071]embedded image [00072]embedded image 13 [00073]embedded image [00074]embedded image [00075]embedded image 14 [00076]embedded image [00077]embedded image [00078]embedded image

    Examples 15 to 20: Asymmetric Addition Reaction Between Imine Having No Substituent on Nitrogen Produced from Silyl Azide Having -Hydrogen and Allylborate Compound

    [0109] In the present Examples, a ruthenium complex A was used to as a catalyst, synthesize an -silylimine intermediate having no substituent on nitrogen from silyl azide having -hydrogen, and at the same time to carry out an asymmetric addition reaction of an allylborate compound, thereby preparing an -silylamine compound.

    [Example 15] Preparation of -Silylamine Compound (R)-15

    [0110] ##STR00079##

    [0111] A ruthenium catalyst A (15.3 mg, 0.015 mmol) was added to THF (0.25 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of trimethylsilylmethyl azide (102.0 mg, 0.75 mmol) and triethyl borane (1M solution in hexane, 0.9 mL, 0.9 mmol) dissolved in THF (0.75 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 1 hour under irradiation of a 30 W fluorescent light, and cooled to 78 C. (-)-Ipc.sub.2B(allyl) borane (1M solution, 1.13 mL, 1.13 mmol) and THF (0.75 mL) were mixed, and cooled to 78 C. The reaction mixture was transferred to the side where the borane solution is present, using a double-ended needle, while maintaining the temperature at 78 C., and then stirred at 78 C. for 10 hours, and chloroform (1 mL) was added thereto, thereby finishing the reaction. Then, the reactant was transferred to a separatory funnel, and then acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (55 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration.

    [0112] The concentrated solution was dissolved in dichloromethane (CH.sub.2Cl.sub.2, 15 mL, 0.05 M) without a further purification process, and then di-tert-butyl dicarbonate (Boc.sub.2O, 246 mg, 1.13 mmol) was added thereto. The reaction mixture was stirred at room temperature for 18 hours, water (10 mL) was added thereto to finish the reaction, and dichloromethane (310 mL) was added thereto for extraction. Water was removed by Na.sub.2SO.sub.4 from collected organic layer, which was then concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm13 cm, eluenthexane: diethyl ether=90:10) gave an -silylamine compound (R)-15 (109.9 mg, 0.452 mmol, 60% yield). Enantiomeric excess value was measured by (R)-16. R.sub.f=0.28 (hexane:Ether=90:10).

    [0113] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.04 (s, 9H), 1.41 (s, 9H), 1.90-2.13 (m, 1H), 2.25-2.38 (m, 1H), 3.00-3.27 (m, 1H), 3.95-4.31 (m, 1H), 4.95-5.08 (m, 1H), 5.79 (ddt, J=16.8, 9.9, 6.9 Hz, 1H); .sup.13C NMR (75 MHz, CDCl.sub.3): =3.0, 28.6, 36.3, 40.5, 79.0, 116.6, 136.7, 156.4; IR: (cm.sup.1) v 3448, 3343, 2978, 2931, 2900, 1700, 1640, 1498, 1366, 1250, 1174; HRMS (FAB+) calcd for C.sub.12H.sub.26NO.sub.2Si: 244.1727, found: 244.1725. [].sub.D.sup.20 +28.3 (c 1.2, CHCl.sub.3).

    [Example 16] Preparation of -Silylamine Compound (R)-16

    [0114] ##STR00080##

    [0115] A ruthenium catalyst A (15.3 mg, 0.015 mmol) was added to THF (0.25 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of trimethylsilylmethyl azide (102.0 mg, 0.75 mmol) and triethyl borane (1M solution in hexane, 0.9 mL, 0.9 mmol) dissolved in THF (0.75 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 1 hour under irradiation of a 30 W fluorescent light, and cooled to 78 C. (-)-Ipc.sub.2B(allyl) borane (1M solution, 1.13 mL, 1.13 mmol) and THF (0.75 mL) were mixed, and cooled to 78 C. The reaction mixture was transferred to the side where the borane solution is present, using a double-ended needle, while maintaining the temperature at 78 C., and then stirred at 78 C. for 10 hours, and chloroform (1 mL) was added thereto, thereby finishing the reaction. Then, the reactant was transferred to a separatory funnel, and then acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (55 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration.

    [0116] An N-para-toluene sulfonyl substituted -silylamine compound (R)-16 (41% yield) was prepared by the method of Example 1, using para-toluene sulfonyl chloride without a further purification process of the concentrated solution.

    [0117] Enantiomeric excess (87%) of was determined by HPLC on a Chiralcel OD column (hexane:2-propanol=98:2; flow rate=1.0 mL/min; UV=254 nm); retention time=15.3 min (R), 18.8 m in (S); [].sub.D.sup.20 +8.9 (c 0.81, CHCl.sub.3).

    [Example 17] Preparation of -Silylamine Compound (R)-17

    [0118] ##STR00081##

    [0119] A ruthenium catalyst A (5.1 mg, 0.005 mmol) was added to THF (0.25 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of dimethylphenylsilylmethyl azide (47.8 mg, 0.25 mmol) and triethyl borane (1M solution in THF, 0.30 mL, 0.30 mmol) dissolved in THF (0.25 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 1 hour under irradiation of a 30 W fluorescent light, and then cooled to 78 C. (-)-Ipc.sub.2B(allyl) borane (1M solution, 0.38 mL, 0.38 mmol) and THF (1.6 mL) were mixed, and cooled to 78 C. The reaction mixture was transferred to the side where the borane solution is present, using a double-ended needle, while maintaining the temperature at 78 C., and then stirred at 78 C. for 10 hours, and chloroform (1 mL) was added thereto, thereby finishing the reaction. Then, the reactant was transferred to a separatory funnel, and then acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (55 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. Purification with preparative TLC (PTLC, 10 cm15 cm, eluenthexane: isopropylamine=95:5) gave an -silylamine compound (R)-17 (31.8 mg, 0.155 mmol, 62% yield). R.sub.f=0.34 (CH.sub.2Cl.sub.2:MeOH=90:10). [].sub.D.sup.22 +11.6 (c 0.43, CHCl.sub.3).

    [Example 18] Preparation of -Silylamine Compound (R)-18

    [0120] ##STR00082##

    [0121] To a solution of -silylamine compound (R)-17 (28.7 mg, 0.14 mmol) and triethylamine (39 L, 0.28 mmol) dissolved in THF (0.7 mL, 0.2 M), benzylchloroformate (21 L, 0.21 mmol) was added. The reaction mixture was stirred at room temperature for 5 hours, water (3 mL) was added thereto to finish the reaction, and then dichloromethane (33 mL) was added thereto for extraction. Water was removed by Na.sub.2SO.sub.4 from collected organic layer, which was then concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm15 cm, eluenthexane:ethyl acetate=90:10) gave an -silylamine compound (R)-18 (34.0 mg, 0.10 mmol, 72% yield). R.sub.f=0.38 (hexane:EtOAc=90:10).

    [0122] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.36 (s, 6H), 2.04 (dt, J=14.4, 8.1 Hz, 1H), 2.36-2.51 (m, 1H), 3.49 (td, J=10.2, 4.2 Hz, 1H), 4.43 (d, J=10.2 Hz, 1H), 4.92-5.13 (m, 4H), 5.63-5.88 (m, 1H), 7.30-7.42 (m, 8H), 7.50-7.59 (m, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =4.7, 4.3, 36.4, 40.9, 66.8, 117.0, 128.2, 128.2, 128.7, 129.8, 134.2, 136.2, 156.9; IR: (cm.sup.1) v 3424, 3330, 3069, 3033, 2960, 1954, 1882, 1816, 1699, 1505, 1428, 1375, 1250, 1113, 1059; HRMS (ESI+) calcd for C.sub.20H.sub.25NO.sub.2SiNa: 362.1547, found: 362.1546.

    [Example 19] Preparation of -Silylamine Compound (R)-19

    [0123] ##STR00083##

    [0124] An -silylamine compound (R)-19 (170.7 mg, 0.80 mmol, 80% yield) was obtained in the same manner as in Example 2, except that trimethylsilylmethyl azide (129.2 mg, 1.00 mmol), a ruthenium catalyst A (20.4 mg, 0.020 mmol), and (R)-trans-oct-2-en-4-yl boronic acid pinacol ester (357.3 mg, 1.5 mmol) were stirred at room temperature for 6 hours under irradiation of a 30 W fluorescent light. R.sub.f=0.46 (CH.sub.2Cl.sub.2:MeOH=90:10). Enantiomeric excess was measured by (R)-20. [].sub.D.sup.20 +30.0 (c 0.50, CHCl.sub.3).

    [Example 20] Preparation of -Silylamine Compound (R)-20

    [0125] ##STR00084##

    [0126] An N-para-toluene sulfonyl substituted -silylamine compound (R)-20 (140.7 mg, 0.383 mmol, 83% yield) was obtained in the same manner as in Example 1, using the -silylamine compound (R)-19 and para-toluene sulfonyl chloride. R.sub.f=0.45 (hexane:EtOAc=90:10). m.p. 108 C.

    [0127] .sup.1H NMR (500 MHz, CDCl.sub.3): =0.11 (s, 9H), 0.98 (d, J=6.5 Hz, 3H), 2.41 (s, 3H), 2.50-2.62 (m, 1H), 3.20-3.32 (m, 1H), 3.62 (dd, J=16.0, 6.5 Hz, 1H), 3.99 (dd, J=16.0, 6.5 Hz, 1H), 4.63 (d, J=10.5 Hz, 1H), 4.76 (d, J=17.0 Hz, 1H), 5.07-5.21 (m, 2H), 5.39 (ddd, J=17.0, 10.0, 8.4 Hz, 1H), 5.91 (ddd, J=17.0, 10.0, 6.5 Hz, 1H), 7.25 (d, J=8.0 Hz, 2H), 7.68 (d, J=8.0 Hz, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =0.1, 19.7, 21.7, 39.9, 51.5, 57.0, 114.1, 115.6, 127.8, 129.4, 136.4, 139.1, 142.8, 144.1; IR: (cm.sup.1) v 3428, 2957, 2929, 1645, 1320, 1253, 1160, 1095, 1015, 837; HRMS (ESI+) calcd for C.sub.19H.sub.33NO.sub.2SSiNa: 390.1893, found: 390.1891.

    [0128] Enantiomeric excess (89%) was determined by HPLC on a Chiralcel ID column (hexane:2-propanol=98:2; flow rate=0.6 mL/min; UV=254 nm); retention time=25.7 min (R), 27.6 min (S); [].sub.D.sup.20 +30.0 (c 0.37, CHCl.sub.3).

    [0129] It was confirmed from the above Examples 15 to 20 that the -silylamine compound was produced in a high yield by an asymmetric addition reaction between imine having no substituent on nitrogen produced from silyl azide having -hydrogen and an allylborate compound.

    [Example 21] Preparation I of Azacyclic Compound 34 from -Silylamine Compound

    [0130] ##STR00085##

    [0131] Preparation of Compound 31

    [0132] i) Preparation of Intermediate S1

    [0133] A ruthenium catalyst A (61.1 mg, 0.060 mmol) was added to THF (4.0 mL) under the nitrogen atmosphere and stirred for 10 minutes to dissolve the ruthenium catalyst A. A solution of trimethylsilylmethyl azide (517 mg, 4.0 mmol) and trans-crotylboronic acid pinacol ester (1.09 g, 6.0 mmol) dissolved in THF (4.0 mL) was added to the catalyst solution. The reaction mixture was stirred at room temperature for 3 hours under irradiation of a 30 W fluorescent light. When the stirring is completed, chloroform (3 mL) was added thereto to finish the reaction, and the stirring was performed for another 5 minutes. Then, the reactant was transferred to a separatory funnel, and acidified with 1N HCl until the pH was 1, and an aqueous layer was separated therefrom. Then, the aqueous layer was neutralized with 6 N NaOH at 0 C. until the pH was 10. The aqueous layer was extracted with diethyl ether (510 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration.

    [0134] The concentrated solution was directly dissolved in dimethyl formamide (DMF, 16 mL, 0.25 M) without a further purification process. To this solution, allyl bromide (0.38 mL, 4.4 mmol) and potassium carbonate (K.sub.2CO.sub.3, 1.1 g, 8.0 mmol) were added. The reactant was stirred at room temperature for 12 hours, and the reaction was finished by adding 10 mL of water. Then, the reactant was transferred to a separatory funnel, an organic layer and an aqueous layer were separated, and then the aqueous layer was extracted by dichloromethane (310 mL). Water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm13 cm, eluenthexane:ethyl acetate=80:20) gave a compound S1 (609 mg, 3.09 mmol, 77% yield). R.sub.f=0.62 (hexane:EtOAc=80:20).

    [0135] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.05 (s, 9H), 1.06 (d, J=6.8 Hz, 3H), 1.68-1.80 (m, 2H), 2.28-2.43 (m, 4H), 2.69 (dt, J=13.2, 2.9 Hz, 1H), 3.50-3.58 (m, 1H), 5.08-5.19 (m, 2H), 5.56-5.73 (m, 2H), 5.83-6.01 (m, 1H), 7.24 (d, J=8.1 Hz, 2H), 7.69 (d, J=8.1 Hz, 2H); .sup.13C NMR (75 MHz, CDCl.sub.3): =1.0, 18.6, 40.0, 53.2, 53.4, 113.9, 115.8, 137.8, 143.5; IR: (cm.sup.1) v 3449, 3078, 2960, 2929, 1736, 1642, 1454, 1418, 1373, 1248, 1099, 996; HRMS (ESI+) calcd for C.sub.11H.sub.24NSi: 198.1673, found: 198.1672.

    [0136] ii) Preparation of Intermediate S2

    [0137] Compound S1 (600 mg, 3.04 mmol) was dissolved in dichloromethane (CH.sub.2Cl.sub.2, 32 mL, 0.05 M), and then di-tert-butyl dicarbonate (Boc.sub.2O, 1.09 g, 5.01 mmol) was added thereto. The reaction mixture was stirred at room temperature for 18 hours, water (30 mL) was added thereto to finish the reaction, and dichloromethane (330 mL) was added thereto for extraction. Water was removed by Na.sub.2SO.sub.4 from collected organic layer, which was then concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm13 cm, eluenthexane:EtOAc=90:10) gave a compound S2 (817 mg, 2.75 mmol, 90% yield). R.sub.f=0.75 (hexane:EtOAc=90:10).

    [0138] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.08 (s, 9H), 0.98 (d, J=6.6 Hz, 3H), 1.41 (s, 9H), 2.26-2.48 (m, 1H), 2.80-2.97 (m, 1H), 3.34 (dd, J=15.2, 7.4 Hz, 0.7H), 3.44-3.60 (m, 0.3H), 3.98 (dd, J=15.0, 5.9 Hz, 0.7H), 4.05-4.13 (m, 0.3H), 4.86-5.21 (m, 4H), 5.64 (ddd, J=17.1, 10.2, 8.9 Hz, 1H), 5.71-5.88 (m, 1H); .sup.13C NMR (75 MHz, CDCl.sub.3): =0.1, 19.1, 28.9, 38.8, 56.3, 78.9, 113.9, 116.6, 135.8, 144.0, 155.4; IR: (cm.sup.1) v 3079, 2979, 2934, 2903, 1813, 1759, 1688, 1640, 1457, 1248, 1120; HRMS (ESI+) calcd for C.sub.16H.sub.31NO.sub.2SSiNa: 320.2016, found: 320.2021.

    [0139] iii) Preparation of Compound 31

    [0140] Compound S2 (803 mg, 2.7 mmol) and a Grubbs catalyst (1.sup.st generation, 44.4 mg, 5.4 mmol) were dissolved in dichloromethane (54 mL, 0.05 M), and stirred at room temperature for 12 hours. The reaction mixture was concentrated under a condition of reduced pressure. Purification with column chromatography using silica gel (3 cm13 cm, eluenthexane:EtOAc=90:10) gave a compound 31 (551 mg, 2.04 mmol, 76% yield). R.sub.f=0.53 (hexane:EtOAc=90:10).

    [0141] .sup.1H NMR (300 MHz, CDCl.sub.3): =0.01 (s, 9H), 0.98-1.10 (m, 3H), 1.45 (s, 9H), 2.32-2.48 (m, 1H), 3.39-3.70 (m, 2H), 4.10-4.39 (m, 1H), 5.45-5.59 (m, 1H), 5.70-5.73 (m, 1H); .sup.13C NMR (75 MHz, CDCl.sub.3): =1.9, 1.8, 21.7, 21.8, 28.7, 30.5, 30.7, 42.1, 43.0, 47.1, 48.7, 79.2, 79.3, 122.8, 123.4, 130.5, 131.1, 155.7, 155.9; IR: (cm.sup.1) v 3079, 2979, 2934, 2903, 1813, 1688, 1640, 1457, 1372, 1248, 1120, 1073; HRMS (ESI+) calcd for C.sub.14H.sub.27NO.sub.2SSiNa: 292.1703, found: 292.1703.

    [0142] Preparation of Compound 32

    [0143] Compound 31 (500 mg, 1.86 mmol) and Pd/C (22.4 mg) were dissolved in methanol (18.6 mL, 0.1 M), and stirred at room temperature for 6 hours under the hydrogen atmosphere. The reaction mixture was concentrated under a condition of reduced pressure after filtration. Purification with column chromatography using silica gel (3 cm15 cm, eluenthexane:ethyl acetate=90:10) have a compound 32 (393 mg, 1.45 mmol, 78% yield). R.sub.f=0.59 (hexane:EtOAc=90:10).

    [0144] .sup.1H NMR (300 MHz, CDCl.sub.3): Rotamer A: =0.07 (s, 9H), 1.03 (d, J=6.9 Hz, 3H), 1.43 (s, 9H), 1.53-1.76 (m, 4H), 1.95-2.06 (m, 1H), 2.59 (td, J=12.7, 3.0 Hz, 1H), 3.38-3.47 (m, 1H), 4.21 (d, J=11.4 Hz, 1H); Rotamer B: =0.07 (s, 7.2H), 1.03 (d, J=6.9 Hz, 2.4H), 1.43 (s, 7.2H), 1.53-1.76 (m, 3.2H), 1.95-2.06 (m, 0.8H), 2.74-2.85 (m, 0.8H), 3.38-3.47 (m, 0.8H), 3.88 (d, J=12.8 Hz, 0.8H); .sup.13C NMR (75 MHz, CDCl.sub.3): =1.5, 21.7, 22.4, 41.3, 42.4, 117.9, 124.9, 125.9, 127.1, 129.8, 134.9, 138.6, 143.1; IR: (cm.sup.1) v 2977, 2934, 1699, 1423, 1253, 1166, 941; HRMS (ESI+) calcd for C.sub.14H.sub.29NO.sub.2SSiNa: 294.1860, found: 294.1860.

    [0145] Preparation of Amide Compound 33

    [0146] Compound 32 (370 mg, 1.36 mmol) was dissolved in dichloromethane (CH.sub.2Cl.sub.2, 19.4 mL, 0.07 M) and then trifluoroacetic acid (2.1 mL, 27.2 mmol) was added dropwise thereto. The temperature was slowly raised to room temperature, and then stirring was performed for 2 hours. 20 mL of water was added to finish the reaction, and then 6 N NaOH was added to neutralize the reactant. The solution was transferred to a separatory funnel, and then an organic layer and an aqueous layer were separated. The aqueous layer was extracted with diethyl ether (320 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. The concentrated solution was dissolved in dichloromethane (CH.sub.2Cl.sub.2, 27.2 mL, 0.05 M) without a further purification process, and then EDC HCl (391.1 mg, 1.94 mmol) and triethylamine (0.26 mL, 1.84 mmol), 3,4-dimethoxyphenyl acetic acid (266.8 mg, 1.36 mmol) were added thereto at 0 C. The reaction mixture was stirred at room temperature for 24 hours, sat. NH.sub.4Cl (25 mL) was added thereto to finish the reaction, and then diethyl ether (325 mL) was added thereto for extraction. Water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was then concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm12 cm, eluenthexane:ethyl acetate=60:40) gave a compound 33 (353 mg, 1.01 mmol, 74% yield). R.sub.f=0.44 (hexane:EtOAc=60:40).

    [0147] .sup.1H NMR (300 MHz, CDCl.sub.3): Rotamer A: =0.08 (s, 9H), 0.99 (d, J=7.2 Hz, 3H), 1.13-1.44 (m, 1H), 1.45-1.68 (m, 3H), 1.76-1.96 (m, 1H), 2.78-2.96 (m, 1H), 3.66 (br s, 2H), 3.73-3.82 (m, 1H), 3.85 (s, 6H), 4.37 (d, J=5.4 Hz, 1H), 6.70-6.87 (m, 3H); Rotamer B: =0.08 (s, 2.7H), 0.88 (d, J=6.9 Hz, 0.9H), 1.13-1.44 (m, 0.3H), 1.45-1.68 (m, 0.9H), 1.76-1.96 (m, 0.3H), 2.27-2.41 (m, 0.3H), 3.62 (br s, 0.6H), 3.73-3.82 (m, 0.3H), 3.85 (s, 1.8H), 4.67 (dd, J=13.2, 2.1 Hz, 0.3H), 6.70-6.87 (m, 0.9H); .sup.13C NMR (150 MHz, CDCl.sub.3): =0.9, 0.8, 19.8, 20.1, 20.3, 21.7, 28.2, 29.1, 29.2, 40.4, 40.9, 41.0, 45.7, 49.7, 53.4, 55.9, 56.0, 56.1, 111.7, 111.8, 112.1, 112.9, 128.6, 148.0, 149.4, 169.5, 170.1; IR: (cm.sup.1) v 2953, 2870, 2835, 1626, 1590, 1515, 1451, 1261, 1237, 1190, 1153, 1030; HRMS (ESI+) calcd for C.sub.19H.sub.31NO.sub.3SiNa: 372.1965, found: 372.1959.

    [0148] Preparation of Azacyclic Compound 34

    [0149] A flask including ceric ammonium nitrate (164.5 mg, 0.30 mmol) was filled with nitrogen gas, and the amide compound 33 (35.0 mg, 0.10 mmol) was dissolved in MeOH (4.0 mL, 0.025M), which is then transferred to ceric ammonium nitrate. After stirring at room temperature for 12 hours, dichloromethane (5 mL) was added thereto. Then, this solution was washed with sat. NaCl (35 mL). Water was removed by Na.sub.2SO.sub.4 from collected organic layer, which was concentrated under a reduced pressure condition after filtration. The solution remaining after concentration was transferred to a seal tube, which was then filled with nitrogen, and the solution was dissolved in 1,2-dichloroethane (ClCH.sub.2CH.sub.2Cl, 4.0 mL, 0.025 M), and BF.sub.3OTf.sub.2 (50 L, 0.40 mmol) was added dropwise thereto. The reaction mixture was stirred at 80 C. for 24 hours, and then water (5 mL) was added thereto to finish the reaction. Dichloromethane (35 mL) was added to perform extraction from the reaction mixture, and water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm15 cm, eluentCH.sub.2Cl.sub.2:MeOH=95:5) gave an azacyclic compound 34 (20.8 mg, 0.0754 mmol, 75% yield). (R.sub.f=0.82 (CH.sub.2Cl.sub.2:MeOH=90:10).

    [0150] .sup.1H NMR (300 MHz, CDCl.sub.3): major isomer, Rotamer A =0.92 (d, J=6.6 Hz, 3H), 1.21-1.59 (m, 5H), 1.63-1.84 (m, 2H), 1.94 (d, J=11.7 Hz, 1H), 2.58-2.71 (m, 1H), 3.43-3.67 (m, 2H), 3.86 (s, 6H), 4.76 (d, J=12.6 Hz, 1H), 6.59 (s, 2H); major isomer, Rotamer B =0.92 (d, J=6.6 Hz, 0.6H), 1.21-1.59 (m, 1H), 1.63-1.84 (m, 0.4H), 1.94 (d, J=11.7 Hz, 0.2H), 2.18-2.29 (m, 0.2H), 3.43-3.67 (m, 0.4H), 3.86 (s, 1.2H), 4.90 (d, J=11.1 Hz, 1H), 6.59 (s, 0.4H); minor isomer =0.65 (d, J=6.9 Hz, 0.45H), 1.21-1.59 (m, 0.75H), 1.63-1.84 (m, 0.3H), 2.02 (d, J=5.7 Hz, 0.15H), 2.58-2.71 (m, 0.15H), 3.43-3.67 (m, 0.3H), 3.91 (s, 0.9H), 4.56 (br s, 0.15H), 6.52 (s, 0.3H); .sup.13C NMR (75 MHz, CDCl.sub.3): major isomer =19.6, 25.8, 34.8, 36.1, 38.9, 45.2, 56.1, 56.3, 68.2, 110.3, 111.2, 123.9, 124.7, 147.0, 148.8, 168.6; minor isomer =111.1, 14.3, 22.5, 31.5, 37.0, 43.9, 56.3, 107.8, 109.6, 125.1, 148.5, 148.8; IR: (cm.sup.1) v 2925, 2854, 1741, 1649, 1561, 1518, 1460, 1377, 1252, 1119; HRMS (ESI+) calcd for C.sub.16H.sub.21NO.sub.3Na: 298.1414, found: 298.1415.

    [Example 22] Preparation II of Azacyclic Compound 36 from -Silylamine Compound

    [0151] ##STR00086##

    [0152] Preparation of Amide Compound 35

    [0153] Compound 32 (135.7 mg, 0.500 mmol) was dissolved in dichloromethane (CH.sub.2Cl.sub.2, 7.1 mL, 0.07 M), and then trifluoroacetic acid (0.77 mL, 10.0 mmol) was added dropwise thereto. The temperature was slowly raised to room temperature, and then stirring was performed for 2 hours. 10 mL of water was added to finish the reaction, and then 6 N NaOH was added to neutralize the reactant. The solution was transferred to a separatory funnel, and then an organic layer and an aqueous layer were separated. The aqueous layer was extracted with diethyl ether (310 mL), and then water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was concentrated under a reduced pressure condition after filtration. The concentrated solution was dissolved in dichloromethane (CH.sub.2Cl.sub.2, 10.0 mL, 0.05 M) without a further purification process, and then EDC HCl (143.8 mg, 0.75 mmol), triethylamine (94 L, 0.135 mmol) and thiophene 3-acetic acid (71 mg, 0.500 mmol) were added thereto at 0 C. The reaction mixture was stirred at room temperature for 24 hours, sat. NH.sub.4Cl (10 mL) was added thereto to finish the reaction, and then diethyl ether (310 mL) was added thereto for extraction. Water was removed by Na.sub.2SO.sub.4 from the collected organic layer, which was then concentrated under a reduced pressure condition after filtration. Purification with column chromatography using silica gel (3 cm13 cm, eluenthexane:ethyl acetate=40:60) gave a compound 35 (93.1 mg, 0.315 mmol, 63% yield). R.sub.f=0.83 (hexane:EtOAc=40:60).

    [0154] .sup.1H NMR (300 MHz, CDCl.sub.3): Rotamer A: =0.05 (s, 9H), 0.98 (d, J=6.9 Hz, 1H), 1.23-1.52 (m, 3H), 1.58-1.82 (m, 1H), 1.94-2.10 (m, 1H), 2.99 (ddd, J=13.5, 11.1, 3.0 Hz, 1H), 3.63-3.80 (m, 3H), 3.96 (br s, 1H), 6.92-7.15 (m, 2H), 7.25-7.33 (m, 1H); Rotamer B: =0.06 (s, 2.7H), 0.87 (d, J=6.9 Hz, 0.9H), 1.23-1.52 (m, 0.9H), 1.58-1.82 (m, 0.3H), 1.94-2.10 (m, 0.3H), 2.41 (td, J=12.9, 2.7 Hz, 0.3H), 3.63-3.80 (m, 0.6H), 4.70 (dt, J=13.2, 1.9 Hz, 0.3H), 6.92-7.15 (m, 0.6H), 7.25-7.33 (m, 0.3H); .sup.13C NMR (75 MHz, CDCl.sub.3): Rotamer A: =0.6, 20.3, 21.8, 29.2, 29.2, 36.5, 46.1, 49.7, 121.8, 125.9, 135.9, 169.2; Rotamer B: =0.7, 19.8, 20.4, 28.3, 25.8, 41.1, 53.6, 122.4, 125.9, 135.7, 169.8; IR: (cm.sup.1) v 2952, 2870, 1627, 1447, 1431, 1301, 1249, 1133, 830; HRMS (ESI+) calcd for C.sub.15H.sub.25NOSSiNa: 318.1318, found: 318.1318.

    [0155] Preparation of Amide Compound 36

    [0156] An azacyclic compound 36 (13.8 mg, 0.062 mmol, 62% yield) was obtained in the same manner as the preparation process of the azacyclic compound 34 of Example 21, except that the amide compound 35 (29.5 mg, 0.10 mmol) and ceric ammonium nitrate (164.5 mg, 0.30 mmol) were stirred at room temperature for 18 hours.

    [0157] .sup.1H NMR (300 MHz, CDCl.sub.3): major isomer =1.11 (d, J=6.3 Hz, 3H), 1.33-1.78 (m, 5H), 1.88-2.01 (m, 1H), 2.58 (td, J=12.5, 3.5 Hz, 1H), 3.48-3.69 (m, 2H), 4.15 (d, J=10.2 Hz, 1H), 4.83-4.99 (m, 1H), 6.79 (d, J=5.1 Hz, 1H), 7.23 (d, J=5.1 Hz, 1H); minor isomer =0.69 (d, J=6.9 Hz, 0.48H), 1.33-1.78 (m, 0.80H), 1.88-2.01 (m, 0.16H), 2.52-2.68 (m, 0.16H), 3.48-3.69 (m, 0.32H), 4.76-4.82 (m, 0.16H), 6.74 (d, J=4.8 Hz, 0.16H), 7.23 (d, J=5.1 Hz, 0.16H); .sup.13C NMR (75 MHz, CDCl.sub.3): =19.6, 25.7, 33.2, 34.7, 39.9, 44.9, 65.0, 125.2, 126.0, 130.6, 132.2, 167.1; IR: (cm.sup.1) v 2925, 2853, 1640, 1463, 1436, 1412, 1378 1259, 1169, 1131; HRMS (ESI+) calcd for C.sub.12H.sub.16NOS: 222.0947, found: 222.0947.

    INDUSTRIAL APPLICABILITY

    [0158] The method of preparing an -silylamine compound of the present invention may produce various -silylamine compounds from an -silylmethyl azide compound via a nitrogen-unsubstituted -silylimine intermediate through a reaction with various allylboronate compounds under a mild condition in the presence of a metal complex catalyst.

    [0159] In addition, in the preparation method of the present invention, an -silylamine compound having functional groups and multiple stereocenters including high diastereoselectivity and enantioselectivity, and a geometry of double bond, which was not able to be produced in the past, may be prepared by a one-pot reaction, through an addition reaction of an allyl nucleophile of an allylboronate compound.

    [0160] In addition, the -silylamine compound prepared by the preparation method of the present invention may be used in iminium ion-mediated oxidative cyclization under an oxidant condition such as ceric ammonium nitrate (CAN) by utilizing a silyl group.